Counterpoint Mutual Funds’s RXO RXO Stock Holding History

Counterpoint Mutual Funds’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,991	Closed	-$137K	–	455
2022 Q4	$137K	Buy	+7,991	New	+$142K	0.14%	161

Other funds holding RXO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Counterpoint Mutual Funds's RXO Position: Q1 2023 in Review

Counterpoint Mutual Funds sold out of RXO (RXO) in Q1 2023, closing a stake of 7,991 shares — an estimated $137K sold.

Counterpoint Mutual Funds first reported a position in RXO in Q4 2022 and held it in 1 quarter. The position peaked at $137K in Q4 2022. 281 funds tracked by Wall St. Rank hold RXO as of Q1 2023.

Counterpoint Mutual Funds reported no remaining RXO position as of Q1 2023 after selling out during the quarter.
Counterpoint Mutual Funds sold 7,991 RXO shares in Q1 2023, an estimated $137K.
Counterpoint Mutual Funds first reported a position in RXO in Q4 2022 and held it in 1 quarter.
Counterpoint Mutual Funds's RXO position peaked at $137K in Q4 2022.
281 funds tracked by Wall St. Rank held RXO as of Q1 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2023, filed 20 Apr 2023.